Primary |
Skin Wrinkling |
45.5% |
Skin Disorder |
18.2% |
Therapeutic Skin Care Topical |
18.2% |
Drug Therapy |
9.1% |
Wrinkles |
9.1% |
|
Swelling Face |
16.7% |
Application Site Discolouration |
8.3% |
Application Site Swelling |
8.3% |
Incorrect Route Of Drug Administration |
8.3% |
Pruritus |
8.3% |
Self-medication |
8.3% |
Skin Exfoliation |
8.3% |
Skin Warm |
8.3% |
Urticaria |
8.3% |
Visual Impairment |
8.3% |
Weight Decreased |
8.3% |
|
Secondary |
Drug Use For Unknown Indication |
25.0% |
Therapeutic Skin Care Topical |
20.8% |
Skin Wrinkling |
16.7% |
Alagille Syndrome |
8.3% |
Antiretroviral Therapy |
8.3% |
Measles |
8.3% |
Skin Disorder |
8.3% |
Dry Skin Prophylaxis |
4.2% |
|
Patent Ductus Arteriosus |
14.3% |
Pruritus |
14.3% |
Vomiting |
14.3% |
Application Site Swelling |
7.1% |
Benign Intracranial Hypertension |
7.1% |
Burns Second Degree |
7.1% |
Product Quality Issue |
7.1% |
Renal Failure Acute |
7.1% |
Retinopathy |
7.1% |
Swelling Face |
7.1% |
Urticaria |
7.1% |
|
Concomitant |
Drug Use For Unknown Indication |
26.4% |
Prophylaxis |
11.0% |
Rheumatoid Arthritis |
7.3% |
Hypertension |
7.1% |
Colorectal Cancer Metastatic |
6.4% |
Hiv Infection |
4.8% |
Multiple Myeloma |
4.4% |
Gastrooesophageal Cancer |
4.2% |
Vitamin Supplementation |
4.2% |
Pain |
3.5% |
Diabetes Mellitus |
2.7% |
Folliculitis |
2.7% |
Asthma |
2.4% |
Product Used For Unknown Indication |
2.0% |
Lung Transplant |
1.8% |
Macular Degeneration |
1.8% |
Mineral Supplementation |
1.8% |
Psychotic Disorder |
1.8% |
Type 2 Diabetes Mellitus |
1.8% |
Breast Cancer |
1.6% |
|
Hemiparesis |
10.5% |
Weight Decreased |
8.1% |
Thrombocytopenia |
7.0% |
Cerebral Infarction |
5.8% |
Feeding Disorder |
5.8% |
Stomatitis |
5.8% |
Weight Increased |
5.8% |
Aspartate Aminotransferase Increased |
4.7% |
Drug Interaction |
4.7% |
Hepatitis C |
4.7% |
Injection Site Pain |
4.7% |
Pruritus |
4.7% |
Pruritus Generalised |
4.7% |
Dyspnoea |
3.5% |
Muscular Weakness |
3.5% |
Neutropenia |
3.5% |
Pain In Jaw |
3.5% |
Rash |
3.5% |
Renal Failure Acute |
3.5% |
Cardiac Failure Congestive |
2.3% |
|